These ASX blue-chip shares could rise 25%+ in 2024

Analysts are tipping big returns from these blue chips this year.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX 200 index is home to a good number of quality blue-chip shares with strong business models and positive long-term growth outlooks.

But which ASX blue-chip shares could generate strong returns over the next 12 months?

Two that analysts are tipping as buys with big return potential are listed below. Here's what they are saying about them:

A man with a yellow background makes an annoncement, indicating share price changes on the ASX

Image source: Getty Images

ResMed Inc (ASX: RMD)

Goldman Sachs believes that the ResMed sell-off has created a compelling buying opportunity for investors.

It recently retained its buy rating with a $32 price target, which suggests a potential upside of 26% for investors over the next 12 months. Its analysts see asymmetric upside risk at current levels. They explain:

[W]e believe the perceived downside risk from GLP-1/GIPs has been over-capitalised at RMD's current valuation. Overall, we reduce our TP -3% (with our earnings upgrades offset by mark to market multiples today), and continue to see asymmetric upside risk from current levels and reiterate our Buy rating.

Treasury Wine Estates Ltd (ASX: TWE)

Another blue chip ASX share that could generate big returns for investors is wine giant Treasury Wine.

Morgans currently has an add rating and a $14.15 price target on its shares, which implies a potential upside of over 30% for investors over the next 12 months.

The broker was happy with its recent US acquisition and believes it will be a boost to its margins. It said:

It may take some time for the market to digest TWE's acquisition of Paso Robles luxury wine business, DAOU Vineyards (DAOU) for US$900m (A$1.4bn) given it required a large capital raising. The acquisition is in line with TWE's premiumisation and growth strategy and will strengthen a key gap in Treasury Americas (TA) portfolio. Importantly, DAOU has generated solid earnings growth and is a high margin business. It consequently allowed TWE to upgrade its margins targets. While not without risk given the size of this transaction, if TWE delivers on its investment case, there is material upside to our valuation.

In addition, Morgans highlights that the ASX blue-chip share could be given a major lift if China removes its tariffs. It adds:

The key near term share price catalyst is if China removes the tariffs on Australian wine imports.

Motley Fool contributor James Mickleboro has positions in ResMed and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Four business people wearing formal business suits and ties walk abreast on a wide paved surface with their long shadows falling on the ground ahead of them.
Blue Chip Shares

How did these ASX blue-chip shares perform in March?

Did these blue-chips beat the market in March?

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Blue Chip Shares

Are these ASX blue chips now too cheap to ignore?

Let's see why these shares could be seriously undervalued at current levels.

Read more »

A woman gives two fist pumps with a big smile as she learns of her windfall, sitting at her desk.
Blue Chip Shares

3 reasons to buy Wesfarmers shares today

The retail conglomerate is a no-brainer buy in my book.

Read more »

ASX shares buy Street signs stating 'Winners' and 'Losers' in front of urban backdrop
Blue Chip Shares

How are these 5 ASX share giants really tracking in 2026?

Some are struggling, while others are thriving, proving that opportunity is never far away.

Read more »

Happy work colleagues give each other a fist pump.
Blue Chip Shares

My best blue-chip ASX 200 buys for April

Looking for quality in uncertain markets? These three ASX 200 shares stand out to me.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »

A happy woman stands outside a building looking at her phone and smiling widely.
Blue Chip Shares

I think smart investors should buy these ASX 200 blue-chip shares with $10,000

Looking for ideas? Here are three ASX 200 blue chips that could help build long-term wealth.

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Blue Chip Shares

Would I buy BHP, CBA, and CSL shares today?

These three ASX 200 leaders have taken different paths lately. Here’s how I’d think about them right now.

Read more »